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Acton D, Miles GB. Differential regulation of NMDA receptors by
D-serine and glycine in mammalian spinal locomotor networks. J
Neurophysiol 117: 1877–1893, 2017. First published February 15,
2017; doi:10.1152/jn.00810.2016.—Activation of N-methyl-D-aspar-
tate receptors (NMDARs) requires the binding of a coagonist, either
D-serine or glycine, in addition to glutamate. Changes in occupancy of
the coagonist binding site are proposed to modulate neural networks
including those controlling swimming in frog tadpoles. Here, we
characterize regulation of the NMDAR coagonist binding site in
mammalian spinal locomotor networks. Blockade of NMDARs by
D()-2-amino-5-phosphonopentanoic acid (D-APV) or 5,7-dichlo-
rokynurenic acid reduced the frequency and amplitude of pharmaco-
logically induced locomotor-related activity recorded from the ventral
roots of spinal-cord preparations from neonatal mice. Furthermore,
D-APV abolished synchronous activity induced by blockade of inhib-
itory transmission. These results demonstrate an important role for
NMDARs in murine locomotor networks. Bath-applied D-serine en-
hanced the frequency of locomotor-related but not disinhibited burst-
ing, indicating that coagonist binding sites are saturated during the
latter but not the former mode of activity. Depletion of endogenous
D-serine by D-amino acid oxidase or the serine-racemase inhibitor
erythro--hydroxy-L-aspartic acid (HOAsp) increased the frequency
of locomotor-related activity, whereas application of L-serine to en-
hance endogenous D-serine synthesis reduced burst frequency, sug-
gesting a requirement for D-serine at a subset of synapses onto
inhibitory interneurons. Consistent with this, HOAsp was ineffective
during disinhibited activity. Bath-applied glycine (1–100 M) failed
to alter locomotor-related activity, whereas ALX 5407, a selective
inhibitor of glycine transporter-1 (GlyT1), enhanced burst frequency,
supporting a role for GlyT1 in NMDAR regulation. Together these
findings indicate activity-dependent and synapse-specific regulation
of the coagonist binding site within spinal locomotor networks,
illustrating the importance of NMDAR regulation in shaping motor
output.
NEW & NOTEWORTHY We provide evidence that NMDARs
within murine spinal locomotor networks determine the frequency and
amplitude of ongoing locomotor-related activity in vitro and that
NMDARs are regulated by D-serine and glycine in a synapse-specific
and activity-dependent manner. In addition, glycine transporter-1 is
shown to be an important regulator of NMDARs during locomotor-
related activity. These results show how excitatory transmission can
be tuned to diversify the output repertoire of spinal locomotor net-
works in mammals.
motor control; central pattern generator; spinal cord; neuromodulation
DURING LOCOMOTOR BEHAVIORS, such as walking, running, and
swimming, the coordination and timing of muscle activation
are determined by central pattern generator (CPG) networks
within the spinal cord (Kiehn 2016). In mammals, excitatory
glutamatergic transmission controls the frequency and intensity
of network output (Kiehn et al. 2008; Talpalar and Kiehn 2010)
and contributes to gait selection (Bellardita and Kiehn;
2015Crone et al. 2009; Talpalar et al. 2013). Modulation of
excitatory signaling therefore underlies behavioral responses to
challenges presented by the external environment (Bellardita
and Kiehn 2015; Grillner 2006; Orlovsky et al. 1999).
Endogenous glutamate acts via both N-methyl-D-aspartate
(NMDA) receptors (NMDARs) and non-NMDARs, namely
-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
(AMPA) and kainate receptors, with blockade of either result-
ing in alterations to locomotor-related output in mammals
(Beato et al. 1997; Cazalets et al. 1992; Douglas et al. 1993;
Talpalar and Kiehn 2010; Whelan et al. 2000). In isolated rat
spinal cord preparations, blockade of NMDARs results in
either pronounced reductions in the frequency and amplitude of
locomotor-related rhythmic activity or cessation of activity
(Beato et al. 1997; Bracci et al. 1998; Cowley et al. 2005). By
contrast, blockade of NMDARs has been reported to increase
the frequency of locomotor-related activity in mice (Whelan et
al. 2000). It is unclear whether these disparate findings reflect
fundamental differences in glutamatergic signaling between
species or methodological differences between studies.
Unlike non-NMDARs, canonical GluN1/GluN2 subunit-
containing NMDARs require the binding of a coagonist in
addition to glutamate for their activation (Clements and West-
brook 1991; Johnson and Ascher 1987; Kleckner and
Dingledine 1988; Paoletti et al. 2013). In the brain, the endog-
enous coagonist may be either glycine or D-serine, with one or
the other dominating at a given synapse (Henneberger et al.
2010, 2013; Kalbaugh et al. 2009; Le Bail et al. 2015; Li et al.
2009, 2013; Meunier et al. 2016; Mothet et al. 2000; Papouin
et al. 2012). By comparison, little is known about coagonist
identity in the spinal cord.
Concentrations of D-serine in the mammalian spinal cord are
considerably lower than those of glycine, and much lower than
those detected in the brain (Miyoshi et al. 2012; Schell et al.
1997; Sasabe et al. 2007; Thompson et al. 2012). On this basis,
glycine was proposed as the exclusive coagonist of NMDARs
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in the spinal cord (Schell et al. 1997). However, beneficial
effects of D-serine degradation in rodent pain studies (Lefèvre
et al. 2015; Moon et al. 2015) and data implicating aberrant
D-serine metabolism in the pathogenesis of amyotrophic lateral
sclerosis (ALS) (Mitchell et al. 2010; Paul and de Belleroche
2014; Sasabe et al. 2007) highlight the importance of further
investigation into the role of D-serine in spinal cord physiology.
Glycine availability at excitatory synapses is tightly regu-
lated by glycine transporter 1 (GlyT1) (Berger et al. 1998;
Bergeron et al. 1998; Supplisson and Bergman 1997). Block-
ade of GlyT1 enhances rhythmic activity in spinal locomotor
networks in Xenopus tadpoles, implying a role for glycine
transport in the regulation of swimming (Issberner and Sillar
2007). Inhibition of GlyT1 also facilitates NMDAR activation
in spinal forelimb networks in rats (Shimomura et al. 2015);
however, it is unknown whether GlyT1 regulates rhythmic
locomotor-related activity in mammals, and evidence that en-
dogenous glycine gates NMDARs in the spinal cord is lacking.
Occupancy of the coagonist binding site is proposed to be
regulated in an activity-dependent manner, resulting in dy-
namic modulation of NMDAR activation (Kalbaugh et al.
2009; Li et al. 2009, 2013). An unsaturated coagonist binding
site could permit the regulation of glutamatergic signaling by
adjustments to coagonist availability (Berger et al. 1998; Li et
al. 2009, 2013). It has been shown that the coagonist binding
site is unsaturated in rat in vitro spinal cord preparations
(Brugger et al. 1990; Shimomura et al. 2015) and within the
spinal cords of Xenopus tadpoles during swimming (Issberner
and Sillar 2007). These reports suggest that changes in coago-
nist availability could modulate excitatory transmission within
mammalian spinal locomotor networks to regulate behavior.
Although the gating of NMDARs via the coagonist binding
site has been proposed as an important mechanism for dynamic
regulation of glutamatergic transmission in spinal locomotor
networks of frog tadpoles, ultimately determining behavioral
output (Issberner and Sillar 2007), its role in the production of
locomotor-related activity in mammals has not been character-
ized. In this study, we examine coagonist regulation of
NMDARs during network activity in spinal cord preparations
from postnatal mice. We show that blockade of NMDARs
reduces the frequency and amplitude of rhythmic activity,
whereas increasing coagonist availability enhances network
activity. Furthermore, we show that occupancy of the coagonist
binding site varies with the intensity of network activity,
implying activity-dependent regulation. We also provide evi-
dence that endogenous glycine and D-serine regulate NMDARs
in a synapse-specific manner and have opposing actions on the
frequency of network output. Finally, we demonstrate that
GlyT1 is a potent regulator of activity at excitatory synapses.
Together, these findings reveal the importance of coagonist
binding site regulation during behaviorally relevant activity in
a mammalian network.
METHODS
Tissue preparation. All procedures performed on animals were
conducted in accordance with the UK Animals (Scientific Procedures)
Act 1986 and were approved by the University of St Andrews Animal
Welfare and Ethics Committee. Spinal cords were isolated from
postnatal day (P)1–P4 C57BL/6 mice as previously described (Jiang
et al. 1999). In summary, animals were killed by cervical dislocation,
decapitated, and eviscerated, before being transferred to a dissection
chamber containing artificial cerebrospinal fluid (aCSF; equilibrated
with 95% oxygen, 5% carbon dioxide, ~4°C). Spinal cords were then
isolated between midthoracic and upper sacral segments, and ventral
and dorsal roots were trimmed.
Ventral root recordings. Isolated spinal cords were pinned ventral-
side up in a recording chamber perfused with aCSF (equilibrated with
95% oxygen, 5% carbon dioxide; room temperature) at 10 ml/min. Glass
suction electrodes were attached to the first or second lumbar ventral
roots (L1, L2) on each side of the spinal cord to record flexor-related
activity. In some experiments a further suction electrode was attached to
the fifth lumbar ventral root (L5) to record the corresponding extensor-
related activity. Locomotor-related activity was evoked by bath applica-
tion of 5-hydroxytryptamine (5-HT; 15 M) and dopamine (DA; 50 M)
and was characterized by rhythmic bursting alternating contralaterally
between upper ventral roots and ipsilaterally between upper ventral roots
and L5. For disinhibited preparations (Bracci et al. 1996a; Witts et al.
2012), strychnine (1 M) and picrotoxin (60 M) were applied to evoke
rhythmic bursting that was synchronous in all roots. In some experiments,
D()-2-amino-5-phosphonopentanoic acid (D-APV; 50 M) or erythro-
-hydroxy-L-aspartic acid (HOAsp; 400 M) were bath applied at the
onset of locomotor-related bursting. Any drugs present during the control
period were also present during application of further drugs and during
washout. In all experiments, stable rhythmic bursting was established
over a period of ~1 h before the control period. Rhythmic bursting was
considered stable when the frequency, amplitude, and duration of bursts
were unchanged over several minutes. Data were amplified and filtered
(band-pass filter 30–3,000 Hz, Qjin Design) and acquired at a sampling
frequency of 6 kHz with a Digidata 1440A analog-digital converter and
Axoscope software (Molecular Devices, Sunnyvale, CA). Custom-built
amplifiers (Qjin Design) enabled simultaneous online rectification and
integration (50-ms time constant) of raw signals.
Data analysis. Data were analyzed offline with DataView software
(courtesy of Dr W. J. Heitler, University of St Andrews). Ventral-root
bursts were identified from rectified/integrated traces; peak-to-peak am-
plitudes and durations were then measured from the corresponding raw
traces. Amplitude was measured as a noncalibrated unit and is presented
here in arbitrary units. For clarity, data in time-course plots are reported
normalized to control values; however, all statistical analyses were
performed on raw data. For time-course plots, data were averaged across
1-min bins and normalized to a 10-min precontrol period to permit
comparison between preparations. To assess instantaneous frequency and
amplitude, statistical comparisons were performed on raw data averaged
over 5-min periods or 10-min periods for disinhibited preparations. Data
were analyzed with Student’s t-tests. Circular plots were used to assess
phase relationship between bursts recorded from the left and right sides of
the spinal cord (Crone et al. 2009; Kjaerulff and Kiehn 1996; Witts et al.
2012) (statistiXL software, Nedlands, WA, Australia). Data points rep-
resent the phase of locomotor-related bursts recorded from right ventral
roots. The beginning of the locomotor cycle is defined as the onset of left
ventral root activity and has a value of 0. A value of 0.5 corresponds to
strict alternation between right and left bursts. Rayleigh’s test for unifor-
mity was used to assess mean burst onset time (Crone et al. 2009;
Kjaerulff and Kiehn 1996; Witts et al. 2012). Vector direction represents
mean burst onset time, and vector length represents the concentration of
data points around the mean. All statistical tests were performed in SPSS
Statistics for Windows, version 21.0 (IBM, Armonk, NY) or Excel 2013
(Microsoft, Redmond, WA). P values  0.05 were considered
significant.
Solution, drug, and enzyme preparation. The aCSF used for dis-
sections and recordings contained (in mM) 127 NaCl, 26 NaHCO3, 10
glucose, 3 KCl, 2 CaCl, 1.25 NaH2PO4, and 1 MgCl2. 5,7-Dichlo-
rokynurenic acid (DCKA) was supplied by Abcam (Cambridge, UK);
5-HT, D-amino acid oxidase from porcine kidney (DAAO), D-APV,
D-serine, glycine, L-serine, NMDA, picrotoxin, and strychnine were
supplied by Sigma-Aldrich (Poole, UK); N-[(3R)-3-([1,1=-biphenyl]-
4-yloxy)-3-(4-fluorophenyl)propyl]-N-methylglycine hydrochloride
(ALX 5407) was supplied by Tocris Bioscience (Bristol, UK); HOAsp
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was supplied by Wako Chemicals USA (Richmond, VA). ALX 5407
and picrotoxin were dissolved in DMSO, the concentration of which
did not exceed 0.1% (vol/vol) in working solutions; DCKA and
HOAsp were dissolved in 1 eq. NaOH; all other drugs and DAAO
were dissolved in reverse-osmosis water.
RESULTS
NMDAR activation enhances the frequency and amplitude of
pharmacologically induced locomotor-related activity. Reports
conflict over the contribution of NMDARs to the production of
fictive locomotion in mice (Nishimaru et al. 2000; Talpalar and
Kiehn 2010; Whelan et al. 2000). To assess the role of
NMDARs in isolated spinal cord preparations, we bath applied
D-APV (50 M), a selective, competitive NMDAR antagonist
that interacts with the glutamate-binding site on GluN2 sub-
units, while recording pharmacologically induced (5-HT, 15
M; DA, 50 M), bilaterally alternating locomotor-related
output from lumbar ventral roots. D-APV produced a marked
reduction in the frequency of flexor-related bursting in L2 roots
(64.9  4.6%; P  0.01, n  6), from 0.125  0.016 to
0.043  0.011 Hz (Fig. 1, A and C). The amplitude of loco-
motor-related L2 bursts was also reduced, but to a lesser extent
(16.7  4.4%; Fig. 1, A and D; P  0.05, n  6). Alternation
of bursts between contralateral L2 roots was maintained
throughout the drug application (Fig. 1, A and B; Rayleigh’s
test for uniformity: P  0.001; 100 bursts from 4 prepara-
tions). Extensor-related activity recorded from L5 roots became
indistinct upon application of D-APV (Fig. 1A) and was not
further assessed. No differences were found between the ef-
fects of 50 and 100 M D-APV on either the frequency (P 
0.05; n  6) or amplitude (P  0.05; n  6) of bursting in L2
roots, indicating that receptors were saturated at the lower
concentration, consistent with a previous report (Talpalar and
Kiehn 2010).
To further investigate the contribution of NMDARs to lo-
comotor-related activity, and to confirm the requirement for
occupation of the coagonist binding site, we then applied
DCKA (5 M), a competitive inhibitor of NMDARs acting at
the coagonist binding site on GluN1 subunits (Henderson et al.
1990). Like D-APV, DCKA potently reduced the frequency of
locomotor-related bursting in L2 roots (63.7  7.2%; Fig. 1, E
and G; P 0.01, n 6) and modestly reduced burst amplitude
(14.6  2.6%; Fig. 1, E and H; P  0.05, n  6) without
disrupting left-right alternation (Fig. 1, E and F; Rayleigh’s test
for uniformity: P  0.001; 100 bursts from 3 preparations).
Together, these results indicate a role for NMDARs in con-
trolling the frequency and amplitude of locomotor-related ac-
tivity in mouse spinal cord preparations. Furthermore, these
effects are mediated by canonical GluN1/GluN2 subunit-con-
taining NMDARs (Pachernegg et al. 2012; Paoletti et al. 2013).
The NMDAR coagonist binding site is unsaturated during
fictive locomotion. Although occupancy of the coagonist bind-
ing site by D-serine or glycine is a precondition of NMDAR
activation (Clements and Westbrook 1991; Johnson and As-
cher 1987; Kleckner and Dingledine 1988), coagonist binding
sites within a given receptor population may not be saturated,
in which case coagonist availability may be adjusted to mod-
ulate glutamatergic transmission during network activity
(Berger et al. 1998; Kalbaugh et al. 2009; Li et al. 2009, 2013).
We therefore sought to determine whether coagonist binding
sites are saturated during fictive locomotion by bath applying
D-serine at a range of concentrations (0.01 M, n  7 prepa-
rations; 0.1 M, n  5; 1 M, n  7; 3 M, n  6; duration:
15 min); D-serine, unlike glycine, is not subject to rapid clear-
ance from the synapse (Supplisson and Bergman 1997). D-Ser-
ine increased burst frequency at concentrations of 0.01–3 M
within 1–2 min of application, with the greatest effect at 1 M
(70.9  13.6%; Fig. 2, A, Ci, and E; P  0.01, n  7). At
higher concentrations (Fig. 2, B and Ci), and when applied for
periods longer than 15 min (not shown), rhythmic activity
became disordered, and a smaller effect on burst frequency was
recorded. D-Serine altered burst amplitude only at 1 M, al-
though the reduction detected at that concentration was modest
(8.1  2.1%; Fig. 2, A, Cii, and F; P  0.05, n  7). Alter-
nation of bursts between contralateral L2 roots was maintained
throughout the drug application (Fig. 2, A and D; Rayleigh’s
test for uniformity: P  0.001; 100 bursts from 6 prepara-
tions). Similarly, flexor-related bursting in L5 roots was main-
tained (Fig. 2A). To confirm that the effects of D-serine were
mediated exclusively by NMDARs (Kakegawa et al. 2011), we
applied it during NMDAR blockade. In the presence of satu-
rating D-APV (50 M), D-serine (1–10 M) failed to modulate
either the frequency (Fig. 3, A and B; P  0.05, n  6) or
amplitude (Fig. 3, A and C; P  0.05, n  6) of rhythmic
bursting. These data indicate that NMDARs within the spinal
motor circuitry are unsaturated during fictive locomotion, per-
Fig. 1. NMDARs determine the speed and amplitude of locomotor-related activity in spinal cord preparations from postnatal mice. A: raw (top) and
rectified/integrated (bottom) traces recorded from the left and right L2 ventral roots (L2 L; L2 R) and right L5 ventral root (L5 R), showing the effect of the
competitive glutamate-binding site antagonist D-APV (50 M) on locomotor-related activity induced by 5-HT (15 M) and DA (50 M). B: left-right phase
relationship in control conditions (Bi) and during application of D-APV (Bii). Circular plots represent the onset of locomotor bursts recorded from L2 R ventral
roots (gray dots) in relation to the onset of activity recorded from corresponding L2 L roots (assigned a value of 0) in the same cycle. Vector direction indicates
mean phase, and vector length corresponds to clustering of data points around the mean. We analyzed 100 burst cycles from 4 preparations for each condition.
Ci: locomotor-burst frequency over 5 min during a control period, during a 40-min application of D-APV, and during a 30-min washout (Wash). Individual data
points are shown in gray, and means are represented by black lines; n  6 preparations. Cii: time-course plot of normalized data aggregated into 1-min bins
showing a reduction in burst frequency during D-APV application; n  6. Di: locomotor-burst amplitude over 5 min during a control period, during a 40-min
application of D-APV, and during a 30-min washout; n  6. Dii: time-course plot of normalized data aggregated into 1-min bins showing a reduction in burst
amplitude during D-APV application; n  6. E: raw (top) and rectified/integrated (bottom) traces recorded from L2 L and L2 R showing the effect of the
competitive coagonist binding site antagonist DCKA (5 M) on locomotor-related activity. F: left-right phase relationship in control conditions (Fi) and during
application of DCKA (Fii). Circular plots represent the onset of locomotor bursts recorded from L2 R ventral roots (gray dots) in relation to the onset of activity
recorded from corresponding L2 L roots (assigned a value of 0) in the same cycle. Vector direction indicates mean phase, and vector length corresponds to
clustering of data points around the mean. We analyzed 100 burst cycles from 4 preparations for each condition. Gi: locomotor-burst frequency over 5 min
during a control period, during a 30-min application of DCKA, and during a 30-min washout; n  6. Gii: time-course plot of normalized data aggregated into
1-min bins showing a reduction in burst frequency during DCKA application; n  6. Hi: locomotor-burst amplitude over 5 min during a control period, during
a 30-min application of DCKA, and during a 30-min washout; n  6. Hii: time-course plot of normalized data aggregated into 1-min bins showing a reduction in
burst amplitude during DCKA application; n  6. Error bars: SE. Statistically significant difference from control: *P  0.05, **P  0.01. a.u., Arbitrary units.
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mitting enhancement of NMDAR activation and thus network
activity when coagonist concentration is increased.
Endogenous D-serine acts via NMDARs to reduce the fre-
quency of locomotor-related activity. In the brain, the endog-
enous NMDAR coagonist is either D-serine or glycine, with
one or the other gating receptors in a nonredundant manner
(Henneberger et al. 2010, 2013; Kalbaugh et al. 2009; Li et al.
2009, 2013; Le Bail et al. 2015; Meunier et al. 2016; Mothet et
al. 2000; Papouin et al. 2012). We investigated coagonist
identity within spinal networks by selectively depleting endog-
enous D-serine. Unexpectedly, selective degradation of endog-
enous D-serine by bath application of the enzyme DAAO (0.29
U/ml) (Papouin et al. 2012; Sasabe et al. 2014) resulted in a
pronounced increase in the frequency of locomotor-related
bursting (71.6  20.7%; Fig. 4, A and B; P  0.01, n  8) but
did not alter burst amplitude (Fig. 4, A and C; P  0.05, n 
8). Likewise, application of HOAsp (400 M) (Henneberger et
al. 2010; Strˇ íšovský et al. 2005) to inhibit endogenous serine
racemase, which synthesizes D-serine from L-serine (Wolosker
et al. 1999), increased the frequency of rhythmic bursting
(77.9  21.3%; Fig. 4, D and E; P  0.01, n  6) without
affecting amplitude (Fig. 4, D and F; P  0.05, n  6). To
confirm that the increase in locomotor frequency observed
following depletion of endogenous D-serine was mediated by
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Fig. 2. Exogenous D-serine modulates locomotor-related activity. A and B: raw (top) and rectified/integrated (bottom) traces recorded from the left and right L2 ventral
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and DA (50M). C: percentage change in frequency (Ci) and amplitude (Cii) in response to varying concentrations of D-serine, calculated by comparing a 5-min window
during a control period with a 5-min window during a 15-min application of D-serine; n  5–7 preparations. D: left-right phase relationship in control conditions (Di)
and during application of 1M D-serine (Dii). Circular plots represent the onset of locomotor bursts recorded from L2 R ventral roots (gray dots) in relation to the onset of activity
recorded from corresponding L2 L roots (assigned a value of 0) in the same cycle. Vector direction indicates mean phase, and vector length corresponds to clustering of data
points around the mean. We analyzed100 burst cycles from 6 preparations for each condition. Ei: locomotor-burst frequency over 5 min during a control period, during a 15-min
application of D-serine (1 M), and during a 20-min washout. Individual data points are shown in gray, and means are represented by black lines; n 7. Eii: time-course plot
of normalized data aggregated into 1-min bins showing an increase in burst frequency during D-serine (1M) application; n 7. Fi: locomotor-burst amplitude over 5 min during
a control period, during a 15-min application of D-serine (1M), and during a 20-min washout; n 7. Fii: time-course plot of normalized data aggregated into 1-min bins showing
a reduction in burst amplitude during D-serine (1 M) application; n  7. Error bars: SE. Statistically significant difference from control: *P  0.05, **P  0.01.
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NMDARs, we bath applied HOAsp in the presence of D-APV
(50 M). In these experiments, neither burst frequency (Fig. 4,
G and H; P  0.05, n  10) nor amplitude (P  0.05, n  10)
were altered, indicating that endogenous D-serine acts at
NMDARs. However, it is unlikely that endogenous D-serine
acts at all available NMDARs because, if this were the case, its
depletion would result in reduced frequency and amplitude of
locomotor-related bursting, reproducing the effects of global
NMDAR blockade. The finding that depletion of endogenous
D-serine instead increases the frequency of network output
implies that its action is restricted to a subset of NMDARs
within pathways, likely involving inhibitory interneurons, that
control the frequency of locomotor network output. Consistent
with this hypothesis, it was recently shown that selective
inhibition of a subset of glutamatergic neurons, proposed to
synapse onto inhibitory spinal interneurons, enhances locomo-
tor activity (Bouvier et al. 2015).
To further investigate the activity of endogenous D-serine,
experiments were performed in which the substrate of serine
racemase, L-serine, was applied to preparations. Whereas bath-
applied D-serine is expected to potentiate all NMDARs at
which the coagonist binding site is unsaturated, application of
L-serine is expected to enhance the availability of D-serine
preferentially at synapses proximate to its synthesis (Rosen-
berg et al. 2010). The above experiments, in which DAAO and
HOAsp were applied to reduce the actions of endogenous
D-serine, suggest that D-serine is required at a subset of syn-
apses, potentially onto inhibitory interneurons; L-serine appli-
cation is therefore predicted to inhibit network output, having
an effect opposite to that of DAAO and HOAsp. In agreement
with this model, supplementation of L-serine (40–100 M)
consistently reduced the frequency of locomotor-related burst-
ing 16.2  3.6%; Fig. 5, A and B; P  0.01, n  9), without
affecting amplitude (P  0.05, n  9). Burst frequency was
unchanged when L-serine (50 M) was applied in the presence
of HOAsp (400 M; Fig. 5, C and D; P  0.05, n  6),
indicating that serine racemase is required for its conversion to
D-serine, which in turn facilitates NMDAR activation. Collec-
tively, these data support a role for endogenous D-serine in the
regulation of a restricted population of NMDARs in the spinal
cord, with glycine acting as the coagonist at the remaining
fraction.
D-serine does not modulate excitatory components of loco-
motor networks during disinhibited bursting. If endogenous
D-serine acts as the dominant coagonist at a subset of
NMDARs, it is likely that these are expressed by inhibitory
interneurons that constrain the frequency of locomotor-related
activity. To compare the sensitivity of excitatory and inhibitory
components of the spinal motor circuitry to D-serine, we
performed experiments in which inhibitory transmission was
blocked by the glycine-receptor (GlyR) antagonist strychnine
(1 M) and the GABAA-channel antagonist picrotoxin (60
M) (Bracci et al. 1996a; Foster et al. 2014; Witts et al. 2012).
When isolated in this way, excitatory network components
produced slow (0.032  0.002 Hz, n  25), long-duration,
high-amplitude bursts that were synchronous across ventral
roots (Figs. 6 and 7). When we applied D-APV (50 M) to
determine the importance of NMDARs for the generation of
this pattern of network activity, bursting rapidly ceased in all
experiments (Fig. 6, A, Bii, and Cii; n  6), as previously
reported in rats (Bracci et al. 1996a). In two of six experi-
ments, however, bursting recovered during the period of
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D-APV application at a reduced frequency (Fig. 6B) and
amplitude (Fig. 6C), indicating that NMDARs contribute to
network excitation within disinhibited preparations, but are
not indispensable. We also applied NMDA (10 M) to
confirm that NMDAR activation could be enhanced during
disinhibited bursting. NMDA consistently increased burst
frequency (221.2  28.1%; Fig. 6, D and E; P  0.001, n 
6), as previously reported in rats (Bracci et al. 1996b), while
reducing burst amplitude (20.1  5.0%; Fig. 6, D and F;
P  0.05, n  6).
Next, we applied D-serine (1–10 M) to assess whether
NMDAR currents can be modulated via the coagonist binding
site during disinhibited activity. Neither burst frequency (Fig.
7, A and B; P  0.05, n  6) nor amplitude (Fig. 7, A and C;
P  0.05, n  6) were altered, indicating that NMDARs
expressed by excitatory components of the locomotor circuitry
have saturated coagonist binding sites under disinhibited con-
ditions. To assess whether endogenous D-serine acts as an
NMDAR coagonist within excitatory components of the loco-
motor circuitry, we applied HOAsp (400 M) during disinhib-
ited activity. Bursting was unchanged in both frequency (Fig.
7, D and E; P  0.05, n  7) and amplitude (Fig. 7, D and F;
P  0.05, n  7) during HOAsp application, indicating that
D-serine is not required as a coagonist by NMDAR populations
involved in the production of disinhibited bursting. These
results support differential regulation of spinal cord NMDARs
via the coagonist binding site, whereby endogenous D-serine is
required by NMDARs expressed by inhibitory components of
the circuitry only, and receptors are saturated under some
conditions but not others.
GlyT1 regulates extracellular glycine concentration and
NMDAR activity. Because the action of endogenous D-serine
appears limited to a subpopulation of NMDARs within spinal
networks, we next considered the role of glycine in the gating
of NMDARs during bilaterally alternating locomotor-related
activity. Although glycine is the principal inhibitory transmit-
ter within the spinal cord (Bowery and Smart 2006) and has a
similar binding affinity and potency to D-serine at NMDAR
coagonist binding sites (Brugger et al. 1990; Chen et al.
2008; Priestley et al. 1995), application of glycine did not
modulate the frequency or amplitude of rhythmic activity at
1 M (frequency: P  0.05, n  6; amplitude: P  0.05,
n  6), 10 M (frequency: P  0.05, n  6; amplitude: P 
0.05, n  6) or 100 M (frequency: P  0.05, n  6;
amplitude: P  0.05, n  6; Fig. 8, A, C, and D), nor was
left-right alternation of bursting altered (Fig. 8, A and B;
Rayleigh’s test for uniformity: P  0.001; 100 bursts from
3 preparations).
The glycine transporter GlyT1 is highly expressed at excit-
atory synapses in both the spinal cord and brainstem (Cubelos
et al. 2005; Zafra et al. 1995b) and has been proposed to
maintain sub-saturating concentrations of glycine in the latter
(Berger et al. 1998; Lim et al. 2004). To determine the
influence of GlyT1 on extracellular glycine and locomotor-
related network activity, we applied the selective GlyT1 an-
tagonist ALX 5407 (30 M) (Atkinson et al. 2001). GlyT1
antagonism resulted in a gradual increase in burst frequency
(52.0  13.9%; Fig. 8, E and F; P  0.01, n  6) but had no
effect on amplitude (Fig. 8, E and G; P  0.05, n  6). By
contrast, no changes in locomotor frequency (Fig. 8, H and I;
P  0.05, n  6) or amplitude (P  0.05, n  6) were
observed when ALX 5407 (30 M) was applied in the pres-
ence of D-APV (50 M). Together, these results indicate that
GlyT1 governs occupation of NMDAR coagonist binding sites
by exercising stringent control over the concentration of gly-
cine at excitatory synapses.
DISCUSSION
We provide evidence that both endogenous D-serine and
glycine gate NMDARs within mammalian spinal networks to
regulate the frequency of locomotor-related activity, that the
NMDAR coagonist binding site at which they act is unsatu-
rated during locomotor-related but saturated during disinhib-
ited activity, and that the glycine transporter GlyT1 is a potent
regulator of glycine concentration at excitatory synapses.
These findings suggest that dynamic regulation of NMDARs
via the coagonist binding site extends the output repertoire of
mammalian spinal motor circuits, thereby facilitating appropri-
ate behavior.
Excitatory glutamatergic transmission is fundamental to the
operation of spinal networks in both mammalian and nonmam-
malian vertebrates (Alford and Grillner 1990; Brodin et al.
1985; Cazalets et al. 1992; Dale and Roberts 1985; Douglas et
al. 1993; Fenaux et al. 1991; MacDermott and Dale 1987). In
mammals, glutamatergic transmission operates within spinal
locomotor networks to determine the frequency, amplitude,
and robustness of rhythmic activity (Talpalar and Kiehn 2010).
In addition, glutamate released onto spinal networks from
descending pathways mediates commands for both the initia-
tion (Hägglund et al. 2010; Jordan et al. 2008) and cessation
(Bouvier et al. 2015) of locomotion. Glutamatergic signaling
within spinal networks is mediated by both NMDARs and
Fig. 4. Endogenous D-serine acts via NMDARs to modulate the frequency but not the amplitude of locomotor-related activity. A: raw (top) and rectified/integrated
(bottom) traces recorded from the left and right L2 ventral roots (L2 L; L2 R) showing the effect of the D-serine scavenger DAAO (0.29 U/ml) on
locomotor-related activity induced by 5-HT (15 M) and DA (50 M). Bi: locomotor-burst frequency over 5 min during a control period, during a 40-min
application of DAAO, and during a 40-min washout. Individual data points are shown in gray, and means are represented by black lines; n  8. Bii: time-course
plot of normalized data aggregated into 1-min bins showing an increase in burst frequency during DAAO application; n  8. Ci: locomotor-burst amplitude over
5 min during a control period, during a 40-min application of DAAO, and during a 40-min washout; n  8. Cii: time-course plot of normalized data aggregated
into 1-min bins showing no change in burst amplitude during DAAO application; n  8. D: raw (top) and rectified/integrated (bottom) traces recorded from L2
L and L2 R showing the effect of the serine-racemase inhibitor HOAsp (400 M) on locomotor-related activity. Ei: locomotor-burst frequency over 5 min during
a control period, during a 40-min application of HOAsp, and during a 40-min washout; n  6. Eii: time-course plot of normalized data aggregated into 1-min
bins showing an increase in burst frequency during HOAsp application; n 6. Fi: locomotor-burst amplitude over 5 min during a control period, during a 40-min
application of HOAsp, and during a 40-min washout; n  6. Fii: time-course plot of normalized data aggregated into 1-min bins showing no change in burst
amplitude during HOAsp application; n  6. G: raw (top) and rectified/integrated (bottom) traces recorded from L2 L and L2 R showing the effect of HOAsp
on locomotor-related activity in the presence of the competitive glutamate-binding site antagonist D-APV (50 M). H: locomotor-burst frequency over 5 min
during a control period, during a 30-min application of HOAsp, and during a 20-min washout. D-APV was present throughout; n  10. Error bars:  SE.
Statistically significant difference from control: **P  0.01.
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non-NMDARs (Beato et al. 1997; Cazalets et al. 1992; Nishi-
maru et al. 2000; Talpalar and Kiehn 2010; Whelan et al.
2000). Whereas a role for NMDARs in the operation of spinal
CPGs has been established in lampreys and tadpoles (Alford
and Grillner 1990; Brodin et al. 1985; Dale and Roberts 1985;
MacDermott and Dale 1987; Wallén and Grillner 1987), their
importance for the generation of patterned activity in mamma-
lian networks is less clear. Previously, it was proposed that the
contribution of NMDARs to network output differs between
isolated spinal cord preparations from postnatal rats and mice
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(Nishimaru et al. 2000). In rats, application of NMDAR ago-
nists alone is reported to induce sustained fictive locomotion
(Kudo and Yamada 1987; Smith et al. 1988), whereas in mice
sustained activity is proposed to require 5-HT in addition to
NMDAR agonists (Jiang et al. 1999). In addition, NMDAR
blockade consistently inhibits lumbar rhythmic activity in rats
(Beato et al. 1997; Bracci et al. 1998; Cazalets et al. 1992;
Cowley et al. 2005; Gabbay and Lev-Tov 2004; Smith et al.
1988), whereas in mice, it has been reported to enhance burst
frequency during pharmacologically induced (5-HT, 15 M;
DA, 75 M) fictive locomotion (Whelan et al. 2000). We find
that NMDAR blockade reduces the frequency of fictive loco-
motion in mouse spinal-cord preparations, as previously re-
ported in rat preparations (Beato et al. 1997; Gabbay and
Lev-Tov 2004; Cowley et al. 2005). The reason for the dis-
crepancy between our results and those of Whelan et al. (2000)
is unclear, since pharmacological techniques and recording
conditions were similar between the two studies, and it would
be surprising if the use of different mouse strains (Swiss
Webster vs. C57BL/6) accounted for differences in a funda-
mental signaling mechanism.
We also report that NMDAR blockade reduces burst amplitude,
an observation previously reported in mice (Whelan et al. 2000)
and rats (Beato et al. 1997). As in rat preparations (Beato et al.
1997; Bracci et al. 1998; Cowley et al. 2005), left-right rhythmic
alternation of bursts is maintained during NMDAR blockade. We
do not consider the effects of NMDAR blockade at high frequen-
cies (0.4 Hz) of fictive locomotion, during which it has been
reported to disrupt patterned output by increasing nonresetting
deletions, rather than alter frequency per se (Talpalar and Kiehn
2010). Our data are consistent with previous reports that
NMDARs are not essential for locomotor-related activity in ro-
dents but instead function to regulate its amplitude and pacing, at
least at lower frequencies ( 0.4 Hz) (Beato et al. 1997; Bracci et
al. 1998; Cowley et al. 2005; Talpalar and Kiehn 2010). D-APV,
a competitive inhibitor of the glutamate-binding site, and DCKA,
a competitive inhibitor of the coagonist binding site, have similar
effects on burst frequency and amplitude, revealing a requirement
for binding of both glutamate and a coagonist, and implying that
canonical GluN1/GluN2 subunit-containing NMDARs dominate
in the spinal motor circuitry (Pachernegg et al. 2012; Paoletti et al.
2013).
The finding that extensor-related bursting recorded from L5
roots becomes indistinct upon NMDAR blockade may reflect
relatively weak locomotor drive to the lower lumbar segments
resulting from a rostrocaudal gradient of excitability within the
locomotor circuitry (Bonnot et al. 2002). Consistent with this,
NMDAR activation is not essential for bursting in L5, since L5
bursting continues during NMDAR blockade when a strong
pharmacological stimulus is applied (Talpalar and Kiehn 2010).
However, it cannot be ruled out that NMDAR activation is more
important for the generation of activity in L5 roots compared with
upper lumbar roots. The potential for differential excitatory cou-
pling between network modules at different segmental levels
(Hägglund et al. 2013) remains to be investigated.
We find that blockade of NMDARs results in sustained
abolition of disinhibited bursting in most but not all prepara-
tions. Similarly, it is reported that NMDAR blockade abolishes
disinhibited bursting in rat preparations, except when AMPA
receptor currents are enhanced (Bracci et al. 1996a). Thus
NMDARs make a substantial contribution to disinhibited ac-
tivity in both rats and mice but are not essential for it. As in
bilaterally alternating locomotor-related activity (Beato et al.
1997; Bracci et al. 1998; Cowley et al. 2005; Gabbay and
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was blocked. Ei: ventral-root burst frequency over 10 min during a control period, during a 20-min application of NMDA, and during a 30-min washout; n 
6. Eii: time-course plot of normalized data aggregated into 1-min bins showing an increase in burst frequency during NMDA application; n  6. Fi: ventral-root
burst amplitude over 10 min during a control period, during a 20-min application of NMDA, and during a 30-min washout; n  6. Fii: time-course plot of
normalized data aggregated into 1-min bins showing a reduction in burst amplitude during NMDA application; n  6. Error bars: SE. Statistically significant
difference from control: *P  0.05, ***P  0.001.
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Fig. 7. Neither exogenous nor endogenous D-serine modulates disinhibited activity mediated by excitatory components of locomotor networks. A: raw (top) and
rectified/integrated (bottom) traces recorded from the left and right L2 ventral roots (L2 L; L2 R) showing the effect of D-serine (10 M) applied to preparations
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during a 30-min application of HOAsp, and during a 40-min washout; n  7. Fii: time-course plot of normalized data aggregated into 1-min bins showing no
change in burst amplitude during HOAsp application; n  7. Error bars:  SE.
1887REGULATION OF NMDA RECEPTORS IN SPINAL LOCOMOTOR NETWORKS
J Neurophysiol • doi:10.1152/jn.00810.2016 • www.jn.org
 by 10.220.33.1 on M
ay 22, 2017
http://jn.physiology.org/
D
ow
nloaded from
 
Lev-Tov 2004; Nishimaru et al. 2000; Talpalar and Kiehn
2010; Whelan et al. 2000), disinhibited activity can be sus-
tained during NMDAR blockade when an alternative stimulus
of sufficient intensity is provided. Together, our results confirm
the importance of NMDARs during both locomotor-related and
disinhibited activity in mice, suggesting that NMDARs func-
tion in a similar manner in both mice and rats, by contrast with
previous reports (Nishimaru et al. 2000; Whelan et al. 2000).
The coagonist binding site is reported to be unsaturated in
some preparations (Berger, Dieudonné and Ascher 1998; Kal-
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baughet al. 2009; Le Bail et al. 2015; Li et al. 2009, 2013), but
saturated in others (Li et al. 2009; Shigetomi et al. 2013), and
activity-dependent changes in occupancy of the coagonist
binding site have been reported in the brain (Kalbaugh et al.
2009; Li et al. 2009, 2013). We show that the NMDAR
coagonist binding site is unsaturated during locomotor-related
activity and may be subject to cell type-specific and activity-
dependent regulation. An unsaturated coagonist binding site
would permit the regulation of glutamatergic signaling and
locomotor frequency by adjustments to coagonist availability
(Berger et al. 1998; Li et al. 2009, 2013). We show that
exogenous D-serine acts at NMDARs to increase the frequency
of locomotor-related activity in a dose-dependent manner. The
effective concentrations of exogenous D-serine are consistent
with the binding affinities and potencies reported for D-serine
and glycine, with EC50 values in the range of ~0.1–1.3 M
(Brugger et al. 1990; Chen et al. 2008; Priestley et al. 1995).
However, bursting becomes disrupted at higher concentrations
of D-serine, as previously reported for NMDA itself (Talpalar
and Kiehn 2010), illustrating a requirement for regulation of
NMDARs to ensure correct network activity.
The effect of bath-applied D-serine varies with the mode of
network activity. Despite strong activation of NMDARs during
disinhibited bursting, exogenous D-serine does not modulate
this mode of activity, indicating that the coagonist binding sites
of NMDARs expressed by the cells that generate it are satu-
rated. Although it is uncertain whether populations of rhyth-
mogenic interneurons are identical between disinhibited and
locomotor-related preparations, the requirements for glutama-
tergic signaling and commissural circuit elements during syn-
chronous disinhibited bursting (Bracci et al. 1996b; Talpalar et
al. 2011) support a role for excitatory interneurons in the
generation of this mode of activity, and these cells are pro-
posed to form a rhythmogenic core common to disinhibited and
locomotor-related activity (Bracci et al. 1996b). Thus excit-
atory interneurons likely mediate changes in the frequency of
disinhibited bursting, including the frequency increase ob-
served upon NMDA application, as they do during fictive
locomotion (Kiehn et al. 2008; Kiehn 2016). An alternative
possibility is that NMDA acts directly on motoneuronal
NMDARs to increase the frequency of disinhibited bursting.
However, since the coagonist binding site of motoneuronal
NMDARs is not saturated during network quiescence (Brugger
et al. 1990), an activity-dependent increase in coagonist avail-
ability is also implied in this scenario. Our data therefore imply
differential availability of the coagonist depending on network
activity. This may relate to stronger activation of glutamate
receptors during disinhibited bursting, which is characterized
by high-amplitude, long-duration bursts. Consistent with this
possibility, it is reported that coagonist availability scales with
glutamate release in brain preparations, providing positive
feedback onto excitatory synapses (Li et al. 2009, 2013).
Whereas NMDA and glutamate enhance burst amplitude
during locomotor-related activity at lower concentrations and
reduce it at higher concentrations (Talpalar and Kiehn 2010),
exogenous D-serine only modestly reduces burst amplitude.
Since this effect occurs only at the concentration of D-serine
that most potently increases burst frequency, it may be an
indirect effect of rapid network activity. The failure of D-serine
to enhance burst amplitude at lower doses implies that mo-
toneuronal NMDARs are saturated during locomotor-related
activity. Consistent with this possibility, burst amplitude is also
unchanged when glycine availability is enhanced by blockade
of GlyT1. Amplitude is also unaffected by D-serine application
during disinhibited bursting, although this may be a function of
more intense glutamate release (see above). By contrast, the
coagonist binding site of motoneuronal NMDARs is unsatu-
rated when network activity is silenced by TTX (Brugger et al.
1990). Thus the coagonist site may be subject to cell type-
specific as well as activity-dependent regulation, implying
considerable flexibility in the regulation of coagonist availabil-
ity, serving to extend the range of possible network outputs.
In addition to activity-dependent regulation of coagonist
availability, we provide evidence that the identity of the dom-
inant coagonist differs between populations of NMDARs, with
endogenous D-serine and glycine having distinct effects on
network output. Whereas endogenous D-serine depresses the
frequency of locomotor-related activity, glycine enhances the
frequency of activity. If D-serine were the exclusive coagonist
in spinal locomotor networks, or if it acted in conjunction with
glycine at all NMDARs, its depletion would mimic the effects
of NMDAR inhibition by D-APV or DCKA; that is, it would
reduce the frequency and amplitude of locomotor-related ac-
tivity. Instead, depletion of endogenous D-serine, either with an
enzymatic scavenger or by inhibition of its synthesizing en-
zyme, results in a pronounced increase in burst frequency with
no change in burst amplitude. Conversely, supplementation of
the D-serine precursor L-serine results in a decrease in burst
Fig. 8. GlyT1 glycine transporters control the availability of glycine at excitatory synapses. A: raw (top) and rectified/integrated (bottom) traces recorded from
the left and right L2 ventral roots (L2 L; L2 R) showing the effect of glycine (100 M) on locomotor-related activity induced by 5-HT (15 M) and DA (50
M). B: left-right phase relationship in control conditions (Bi) and during application of 100 M glycine 100 M (Bii). Circular plots represent the onset of
locomotor bursts recorded from L2 R ventral roots (gray dots) in relation to the onset of activity recorded from corresponding L2 L roots (assigned a value of
0) in the same cycle. Vector direction indicates mean phase, and vector length corresponds to clustering of data points around the mean. We analyzed100 burst
cycles from 3 preparations for each condition. Ci: locomotor-burst frequency over 5 min during a control period, during a 15-min application of glycine, and
during a 40-min washout. Individual data points are shown in gray, and means are represented by black lines; n  6. Cii: time-course plot of normalized data
aggregated into 1-min bins showing no change in burst frequency during glycine application; n  6. Di: locomotor-burst amplitude over 5 min during a control
period, during a 15-min application of glycine, and during a 40-min washout; n 6. Dii: time-course plot of normalized data aggregated into 1-min bins showing
no change in burst amplitude during glycine application; n  6. E: raw (top) and rectified/integrated (bottom) traces recorded from L2 L and L2 R showing the
effect of the GlyT1 inhibitor ALX 5407 (30 M) on locomotor-related activity. Fi: locomotor-burst frequency over 5 min during a control period, during a 30-min
application of ALX 5407, and during a 30-min washout; n  6. Fii: time-course plot of normalized data aggregated into 1-min bins showing an increase in burst
frequency during ALX 5407 application; n  6. Gi: locomotor-burst amplitude over 5 min during a control period, during a 30-min application of ALX 5407,
and during a 30-min washout; n  6. Gii: time-course plot of normalized data aggregated into 1-min bins showing no change in burst amplitude during ALX
5407 application; n 6. H: raw (top) and rectified/integrated (bottom) traces recorded from L2 L and L2 R showing the effect of ALX 5407 on locomotor-related
activity in the presence of the competitive glutamate-binding site antagonist D-APV (50 M). I: locomotor-burst frequency over 5 min during a control period,
during a 30-min application of HOAsp, and during a 30-min washout. D-APV was present throughout; n 6. Error bars:  SE. Statistically significant difference
from control: **P  0.01.
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frequency that is dependent on D-serine synthesis. Exogenous
L-serine presumably enhance D-serine production at synapses
where serine racemase is concentrated and D-serine is utilized,
whereas exogenous D-serine potentiates NMDARs at all syn-
apses where the coagonist binding site is unsaturated. The
finding that endogenous D-serine inhibits locomotor-related
activity suggests that it is primarily required at excitatory
synapses onto inhibitory interneurons. Consistent with this
possibility, serine racemase inhibition has no effect when
excitatory components of the network are examined in isola-
tion. As a similar example of excitatory signaling acting to
reduce network activity, glutamatergic signaling onto spinal
cord networks by descending glutamatergic V2a interneurons
mediates inhibition of locomotor-related activity, likely
through excitation of inhibitory interneurons (Bouvier et al.
2015). By contrast, signaling onto the spinal cord network by
a broader population of glutamatergic interneurons stimulates
network activity, masking the influence of V2a cells (Hägglund
et al. 2010). A further example of burst frequency regulation by
inhibitory interneurons is provided by V1 cells, ablation of
which reduces burst frequency (Gosgnach et al. 2006). To-
gether, our observations suggest a model in which D-serine acts
via a subpopulation of NMDARs expressed by inhibitory
interneurons to constrain locomotor speed, with the remaining
moiety of NMDARs being regulated by glycine. These results
are consistent with studies showing differential regulation of
distinct populations of NMDARs by glycine and D-serine in the
brain, where the identity of the dominant coagonist varies with
receptor subunit composition (Kalbaugh et al. 2009; Le Bail et
al. 2015; Papouin et al. 2012) subcellular localization of
NMDARs (Papouin et al. 2012), and activity (Li et al. 2013),
as well as with developmental stage (Le Bail et al. 2015).
Although glycine acts at NMDARs with a similar affinity
and potency to D-serine (Brugger et al. 1990; Chen et al. 2008;
Priestley et al. 1995), which exerts a pronounced effect on the
frequency of locomotor-related activity via NMDARs at 1 M,
exogenous glycine does not perturb locomotor-related activity
at concentrations up to 100 M. Although we cannot eliminate
the possibility that glycine activity at strychnine-sensitive in-
hibitory GlyRs masks opposing activity at NMDARs, it is
unlikely that GlyRs were activated in these experiments, as
glycine has EC50 values two to three orders of magnitude
higher for GlyRs than for NMDARs (Blednov et al. 1996;
Engblom and Akerman 1991; Lewis et al. 1998; Tapia and
Aguayo 1998; Graham et al. 2011; Young and Snyder 1974).
Furthermore, inhibitory effects of glycine are not observed
when the concentration of extracellular glycine is increased by
GlyT1 blockade in the presence of D-APV. The lack of effect
of exogenous glycine in our preparations parallels findings in
the brainstem, where D-serine facilitates NMDAR currents in
the low-micromolar range, but glycine is ineffective at con-
centrations below 100 M unless GlyT1 is inhibited (Berger et
al. 1998). The finding that exogenous glycine lacks effect is
thus likely attributable to powerful glycine clearance by
GlyT1, which is highly expressed in both the spinal cord and
brainstem (Cubelos et al. 2005). GlyT1 is a potent regulator of
glycine availability at excitatory synapses and is capable of
holding glycine at subsaturating concentrations within the
restricted space of the synaptic cleft, even when its concentra-
tion in the surrounding medium is an order of magnitude
greater (Bergeron et al. 1998; Supplisson and Bergman 1997).
Consistent with tight regulation of glycine concentration by
GlyT1 at excitatory synapses within the locomotor circuitry,
we show that GlyT1 antagonism results in an NMDAR-depen-
dent increase in locomotor-burst frequency but not amplitude,
replicating the effect of exogenous D-serine. The effect of
GlyT1 blockade on network activity is therefore likely to result
from the accumulation at excitatory synapses of glycine re-
leased at inhibitory synapses, as previously demonstrated (Ah-
madi et al. 2003; Fern et al. 1996). Consistent with our results,
inhibition of GlyT1 potentiates NMDAR currents in the brain-
stem (Lim et al. 2004) and enhances swimming in Xenopus
tadpoles in a manner resembling application of glycine or
D-serine (Issberner and Sillar 2007). Our data highlight the
importance of GlyT1 in the gating of NMDARs and the
regulation of rhythmic activity in the mouse spinal cord, a role
that is conserved between amphibians and mammals (Issberner
and Sillar 2007).
Modulation of GlyT1 activity to adjust the availability of
glycine at excitatory synapses could provide a mechanism for
the regulation of motor behaviors (Issberner and Sillar 2007).
GlyT1 is modulated, for instance, by protein kinase C, which is
activated by endogenous modulators of locomotor networks
released during network activity, including 5-HT (Anji et al.
2001) and acetylcholine (Sculptoreanu et al. 2001). GlyT1 is
also modulated by brain-derived neurotrophic factor (BDNF)
(Aroeira et al. 2014), which is released in an activity-dependent
manner (Goodman et al. 1996; Marini et al. 1998). Thus GlyT1
is equipped to mediate the dynamic regulation of glycine
availability at excitatory synapses suggested by our data and
may in this way confer flexibility on the output of spinal
networks.
Given that glycine and D-serine appear to have opposite roles
in determining locomotor frequency, activity-dependent
changes in their availability may provide a mechanism for
speed control and perhaps contribute to gait selection (Bel-
lardita and Kiehn 2015; Talpalar and Kiehn 2010; Talpalar et
al. 2013). Activity-dependent increases in D-serine availability
would provide negative feedback onto the network to reduce
locomotor speed, whereas increases in glycine would provide
positive feedback to increase it. The existence of distinct
mechanisms for regulating coagonist availability at NMDARs
expressed by excitatory and inhibitory neurons may in this way
permit glutamatergic signaling to be fine tuned, extending the
range of outputs that can be generated by the locomotor CPG.
Alternatively, simultaneous increases in the availability of fa-
cilitatory glycine and inhibitory D-serine may be important in
stabilizing network output, ensuring smooth movement as
speed changes. Changes in coagonist availability may also be
important in nonrhythmic motor behaviors. For instance, an
increase in coagonist availability resulting from sustained re-
lease of glutamate might be expected during slow, sustained
motor behaviors in which muscle contraction is protracted,
such as standing and grasping. During such activities, release
of a coagonist to potentiate NMDAR currents could help to
maintain activity in motoneurons.
It was beyond the scope of this study to consider the effects
of glycine and D-serine on synaptic potentials recorded from
individual neurons. Future studies should analyze the effects of
glycine and D-serine on NMDAR currents recorded from spe-
cific populations of excitatory and inhibitory neurons and
determine whether currents vary in response to local activity
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and fluctuations in glutamate release. In addition, this study did
not consider which cell types are responsible for the regulation
of coagonist availability. GlyT1 is preferentially expressed by
astrocytes in the gray matter of the spinal cord and brainstem
(Cubelos et al. 2005; Zafra et al. 1995a, 1995b), and astrocytes
are required for the synthesis (Wolosker 2011; Ehmsen et al.
2013), degradation (Sasabe et al. 2014; Verrall et al. 2007) and,
at some synapses, secretion (Henneberger et al. 2010; Mothet
et al. 2005; Verrall et al. 2010; Yang et al. 2003) of D-serine.
Furthermore, proper regulation of the NMDAR coagonist bind-
ing site has been demonstrated to require functional interac-
tions between neurons and astrocytes (Le Bail et al. 2015).
Future studies should therefore address the relative contribu-
tions of astrocytes and neurons to the regulation of the coago-
nist binding site in spinal motor networks.
Regulation of NMDARs is essential to proper functioning of
spinal locomotor networks. In healthy animals, the coagonist
binding site may provide a mechanism by which glutamatergic
signaling is refined, permitting network activity to be adjusted
as required. By contrast, dysregulation of NMDARs in the
spinal cord may result in excitotoxicity (Shleper et al. 2005)
and is implicated in the pathogenesis of ALS (Paul et al. 2014;
Sasabe et al. 2007). This study provides the first evidence that
NMDARs in the spinal cord are regulated by both D-serine and
glycine acting at distinct populations of NMDARs, and that
coagonist availability varies with neuronal activity. Further-
more, GlyT1 is shown to control the availability of glycine at
excitatory synapses. Together, these findings reveal previously
unexplored complexity in glutamatergic signaling during ac-
tivity of mammalian locomotor networks.
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